Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: Preliminary report

Infection

Volumn 30, Issue 5, 2002, Pages 257-261

  Schwenger, V ^a   Mundlein E ^b   Dagrosa, E E ^c   Fahr, A M ^d   Zeier, M ^a   Mikus, G ^a   Andrassy, K ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Fachkrankenhaus Neckargemünd ^*  (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d Laboratory Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; COTRIMOXAZOLE; CYSTEINE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; GANCICLOVIR; GLUTATHIONE; METICILLIN; QUINUPRISTIN; RP 100391; RP 69012; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BILE; BIOACCUMULATION; CASE REPORT; CONCENTRATION RESPONSE; DIALYSIS; DISEASE SEVERITY; DRUG EFFICACY; ENTEROCCOCUS INFECTION; ENTEROCOCCUS FAECIUM; FECES; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER INJURY; MALE; PENICILLIN RESISTANCE; STANDARD; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STEADY STATE;

AGED; AGED, 80 AND OVER; BACTEREMIA; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; FEMALE; FOLLOW-UP STUDIES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 0036386960     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2076-3     Document Type: Article

References (12)

1. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
2. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR Morb Mortal Wkly Rep 1997; 46: 624-626.
3. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
4. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR for the Glycopeptide-Intermediate Staphylococcus aureus Working Group: emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
5. Leclercq R, Courvalin P: Streptogramins: an answer to antibiotic resistance in gram-positive bacteria. Lancet 1998; 352: 591-592.
6. Low DE: Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience. Microb Drug Resist 1995; 1: 223-234.
7. Chevalier P, Rey J, Pasquier O, Leclerc V, Baguet JC, Meyrier A, Harding N, Montay G: Pharmacokinetics of quinupristin/dalfopristin in patients with severe chronic renal insufficiency. Clin Pharmacokinet 2000; 39: 77-84.
8. Drug-induced liver disorders: report of an international consensus meeting: standardization of definitions and criteria of causality assessment of adverse drug reactions. J Clin Pharmacol Ther Toxicol 1990; 28: 317-322.
9. Le Liboux A, Pasquier O, Montay G: Simultaneous high-performance liquid chromatographic determination of quinupristin/dalfopristin and their main metabolites in human plasma. J Chromatogr B 1998; 708: 161-168.
10. Mündlein E, von Baum H, Geiss HK, Springsklee M, Zeier M, Andrassy K: Life-threatening infection with multiresistant Staphylococcus epidermidis in a patient with end-stage renal disease: cure with chloramphenicol and quinupristin/dalfopristin (RP 59500). Infection 1997; 25: 252-254.
11. Chevalier P, Rey J, Boucher E, Denier Y, Le Croz F, Patat A, Harding N, Montay G: Open, comparative study of the pharmacokinetics and safety of a single dose of quinupristin/dalfopristin (Q/D, RP 59500, synercid) in subjects with hepatic cirrhosis and healthy volunteers. 20th International Congress of Chemotherapy (ICC) june 29 - July 3, 1997, Sydney, Australia, abstr. no. 832.
12. Stamatakis MK, Richards JG: Interaction between quinupristin/dalfopristin and cyclosporine. Ann Pharmacother. 1997; 31: 576-578.